Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hjorth

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Immunology|April 23, 2013
Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetesM Pihl, L Akerman, S Axelsson, et al.
British Journal of Haematology|March 1, 1996
Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study GroupF Wisløff, S Eika, E Hippe, et al.
Blood|January 11, 2000
Serum syndecan-1: a new independent prognostic marker in multiple myelomaC Seidel, A Sundan, M Hjorth, et al.
Physical Review Letters|August 11, 2005
Ab-initio coupled-cluster study of 16OM Włoch, D J Dean, J R Gour, et al.
Ecotoxicology and Environmental Safety|December 19, 2014
Comparison of produced water toxicity to Arctic and temperate speciesL Camus, S Brooks, P Geraudie, et al.
Molecular Metabolism|April 6, 2017
Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokinesS Pourteymour, K Eckardt, T Holen, et al.
British Journal of Haematology|March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of LifeM L Stead, J M Brown, G Velikova, et al.
The British Journal of Nutrition|January 8, 2021
No effect of salmon fish protein on 2-h glucose in adults with increased risk of type 2 diabetes: a randomised controlled trialK S Hustad, I Ottestad, M Hjorth, et al.
Blood|September 25, 2001
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone diseaseC Seidel, Ø Hjertner, N Abildgaard, et al.
British Journal of Haematology|October 16, 1999
Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factorsI Turesson, N Abildgaard, T Ahlgren, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Immunology|April 23, 2013
Regulatory T cell phenotype and function 4 years after GAD-alum treatment in children with type 1 diabetesM Pihl, L Akerman, S Axelsson, et al.
British Journal of Haematology|March 1, 1996
Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study GroupF Wisløff, S Eika, E Hippe, et al.
Blood|January 11, 2000
Serum syndecan-1: a new independent prognostic marker in multiple myelomaC Seidel, A Sundan, M Hjorth, et al.
Physical Review Letters|August 11, 2005
Ab-initio coupled-cluster study of 16OM Włoch, D J Dean, J R Gour, et al.
Ecotoxicology and Environmental Safety|December 19, 2014
Comparison of produced water toxicity to Arctic and temperate speciesL Camus, S Brooks, P Geraudie, et al.
Molecular Metabolism|April 6, 2017
Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokinesS Pourteymour, K Eckardt, T Holen, et al.
British Journal of Haematology|March 23, 1999
Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of LifeM L Stead, J M Brown, G Velikova, et al.
The British Journal of Nutrition|January 8, 2021
No effect of salmon fish protein on 2-h glucose in adults with increased risk of type 2 diabetes: a randomised controlled trialK S Hustad, I Ottestad, M Hjorth, et al.
Blood|September 25, 2001
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone diseaseC Seidel, Ø Hjertner, N Abildgaard, et al.
British Journal of Haematology|October 16, 1999
Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factorsI Turesson, N Abildgaard, T Ahlgren, et al.
Pageof 6